{"cluster": 62, "subcluster": 10, "abstract_summ": "In order to assist structure\u2010based discovery efforts for repurposing drugs against this disease, we constructed knowledge\u2010based models of SARS\u2010CoV\u20102 proteins and compared the ligand molecules in the template structures with approved/experimental drugs and components of natural medicines.Rational drug design against emerging threats depends on well\u2010established methodology, mainly utilizing X\u2010ray crystallography, to provide accurate structure models of the macromolecular drug targets and of their complexes with candidates for drug development.It is hoped that this freely provided data will aid in small molecule drug discovery efforts to defeat SARS-CoV-2.A bright spot in the SARS\u2010CoV\u20102 (CoV\u20102) coronavirus pandemic has been the immediate mobilization of the biomedical community, working to develop treatments and vaccines for COVID\u201019.In this work it is presented a virtual screening methodology combining a pharmacophore-based model and an empirical Gibbs free energy-based model for the ligand\u2013protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase III\u03b2 (PI4KIII\u03b2) enzyme, which is related to the development of viral infections (including enteroviruses, SARS coronavirus, and hepatitis C virus), cancers and neurological diseases.Our theoretical models suggest several drugs, such as carfilzomib, sinefungin, tecadenoson, and trabodenoson, that could be further investigated for their potential for treating COVID\u201019.Herein, the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit-to-lead optimization stages.", "title_summ": "Ligand\u2010centered assessment of SARS\u2010CoV\u20102 drug target models in the Protein Data BankKnowledge\u2010based structural models of SARS\u2010CoV\u20102 proteins and their complexes with potential drugsNovel phosphatidylinositol 4-kinases III beta (PI4KIII\u03b2) inhibitors discovered by virtual screening using free energy modelsAn Online Repository of Solvation Thermodynamic and Structural Maps of SARS-CoV-2 Targets.", "title_abstract_phrases": "In order to assist structure\u2010based discovery efforts for repurposing drugs against this disease, we constructed knowledge\u2010based models of SARS\u2010CoV\u20102 proteins and compared the ligand molecules in the template structures with approved/experimental drugs and components of natural medicines.It is hoped that this freely provided data will aid in small molecule drug discovery efforts to defeat SARS-CoV-2.Ligand\u2010centered assessment of SARS\u2010CoV\u20102 drug target models in the Protein Data BankA bright spot in the SARS\u2010CoV\u20102 (CoV\u20102) coronavirus pandemic has been the immediate mobilization of the biomedical community, working to develop treatments and vaccines for COVID\u201019.Rational drug design against emerging threats depends on well\u2010established methodology, mainly utilizing X\u2010ray crystallography, to provide accurate structure models of the macromolecular drug targets and of their complexes with candidates for drug development.In this work it is presented a virtual screening methodology combining a pharmacophore-based model and an empirical Gibbs free energy-based model for the ligand\u2013protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase III\u03b2 (PI4KIII\u03b2) enzyme, which is related to the development of viral infections (including enteroviruses, SARS coronavirus, and hepatitis C virus), cancers and neurological diseases.Our theoretical models suggest several drugs, such as carfilzomib, sinefungin, tecadenoson, and trabodenoson, that could be further investigated for their potential for treating COVID\u201019.Novel phosphatidylinositol 4-kinases III beta (PI4KIII\u03b2) inhibitors discovered by virtual screening using free energy modelsHerein, the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit-to-lead optimization stages."}